ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660029 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660029; 2) Community: the network communities that were significantly associated with the response to NSC 660029; 3) Molecule: the relationships between components within communities and NSC 660029; 4) MDR: the compounds that were significantly associated with the NSC 660029.

NSC Compound Enrichment Correlation
NSC 743220 N2-(4-fluorophenyl)-N3-(2-methoxyphenyl)-5-oxo-7-propyl-5H-[ 1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide 0.043472147060915 0.095818629
NSC 745287 Null 0.043472147060915 0.038204693
NSC 758664 Sirolimus [USAN] 0.043472147060915 0.21992396
NSC 763186 Null 0.043472147060915 0.074392239
NSC 94600 Camptothecin 0.043472147060915 0.3818137
NSC 100071 component of Halotex 0.0434721470609156 -0.093217101
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0434721470609156 0.38967695
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0434721470609156 0.021453109
NSC 26980 Mitomycin 0.0434721470609156 0.53591608
NSC 329691 HM-4 0.0434721470609156 0.10943283
Total:69  Current:62    [First] [Prev] [Next] [Last]